Deficiency of complement factor c5 prevents the progression of biliary fibrosis in bile duct-ligated mice
Johannes Schmitt(University Hospital Zurich), Andreas Geier(Swiss Integrative Center for Human Health), P. Frei(University Hospital Zurich), Karim Sabrane(University Hospital Zurich), Alexander Mark Weber(University Hospital Zurich), Elke Roeb(Justus-Liebig-Universität Gießen), P Zhang(University Hospital Zurich), Yiqing Tian(University Hospital Zurich), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Beat Müllhaupt(University Hospital of Zurich), M Roderfeld(Justus-Liebig-Universität Gießen)
Cited by 0
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k